Anker Lundemose - Saniona AB Independent Director

SANION Stock  SEK 6.34  0.46  1.05%   

Director

Dr. Anker Lundemose M.D. Ph.D. was Independent Member of the Board of Directors of Saniona AB since 2014. He is CoFounder of the Company. He is CEO of Mission Therapeutics Ltd and Biotech Advice Consultancy ApS. He was previously CEO and President in BioNor Pharma ASA. He is also Board Member of Saniona AS Abzena plc and Polytherics Limited. He has experience from business and corporate development as well as RD in several key therapeutic areas including oncology and antiinfectives. He has a comprehensive international experience and network and was responsible for mergers and acquisitions within biotech venture investments and licensing. His background includes biotech startups biotech and big pharma as well as an initial career in academia. He was CEO of Prosidion Ltd in the United Kingdom from 2003 to 2005 Executive Vice President OSI Pharmaceuticals NYC United States and President of Prosidion Ltd from 2005 to 2009. He was Executive Vice President Corporationrationrate Business Development OSI Pharmaceuticals Inc. from 2009 until Astellas Pharmas acquisition of OSI in 2010. He has previously held positions as Managing Director at OSI Pharmas venture arm in Zug Switzerland and as Business Development Director at Novo Nordisk Denmark. He also served as CEO of Biotech Advice Consultancy ApS Member of the Board of Adenium Biotech ApS InteRNA Technologies BV and Topotarget AS. He holds Doctorate of Medicine Doctorate in Philosophy and DMSc in Medical Microbiology degrees. since 2014.
Age 52
Tenure 10 years
Phone45 70 70 52 25
Webhttps://www.saniona.com

Saniona AB Management Efficiency

The company has return on total asset (ROA) of (0.5044) % which means that it has lost $0.5044 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3844) %, meaning that it generated substantial loss on money invested by shareholders. Saniona AB's management efficiency ratios could be used to measure how well Saniona AB manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 92.97 M in total debt with debt to equity ratio (D/E) of 34.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Saniona AB has a current ratio of 1.26, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Saniona AB until it has trouble settling it off, either with new capital or with free cash flow. So, Saniona AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Saniona AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Saniona to invest in growth at high rates of return. When we think about Saniona AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

John BrehmerTF Bank AB
53
Charlotta BjornbergPaulTF Bank AB
44
Martin HenricsonFormPipe Software AB
56
Marcus StorchInvestment AB Oresund
76
Asa EricssonFormPipe Software AB
53
Ole NielsenFormPipe Software AB
N/A
Ronny SchandorphFormPipe Software AB
N/A
Jonathan BurdFormPipe Software AB
N/A
Charlotte HanssonFormPipe Software AB
53
Peter LindstromFormPipe Software AB
47
Eskil ThygesenFormPipe Software AB
N/A
Sebastian TornemanUpsales Technology AB
38
Mark StevensFormPipe Software AB
N/A
Baltsar SahlinUpsales Technology AB
39
Douglas RoosInvestment AB Oresund
49
Annikki SchaeferdiekFormPipe Software AB
48
Erik LindebergFormPipe Software AB
47
Lina EloFormPipe Software AB
49
Anna EngebretsenInvestment AB Oresund
36
Erik SyrenFormPipe Software AB
40
Magnus DybeckInvestment AB Oresund
40
Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 21 people. Saniona AB (SANION) is traded on Stockholm Exchange in Sweden and employs 25 people.

Management Performance

Saniona AB Leadership Team

Elected by the shareholders, the Saniona AB's board of directors comprises two types of representatives: Saniona AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Saniona. The board's role is to monitor Saniona AB's management team and ensure that shareholders' interests are well served. Saniona AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Saniona AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Sundberg, Independent Director
Leif Andersson, Independent Director
Edward Saltzman, Director
Claus Braestrup, Independent Chairman of the Board
Palle Christophersen, Co-Founder and Chief Scientific Officer
Janus Larsen, Chief Officer
deBethizy, Chairman of the Board
MBA MSc, CoFounder CEO
Thomas Feldthus, CFO, Executive Vice President
Joergen Drejer, CEO, Director
Jorgen Drejer, Chairman Founder
Karin Nielsen, Chief Officer
Rami Levin, President
Anker Lundemose, Independent Director
Palle MS, Ex Research
Anita BCom, Chief Officer
Anna Ljung, Director

Saniona Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Saniona AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Saniona AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Saniona Stock analysis

When running Saniona AB's price analysis, check to measure Saniona AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saniona AB is operating at the current time. Most of Saniona AB's value examination focuses on studying past and present price action to predict the probability of Saniona AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Saniona AB's price. Additionally, you may evaluate how the addition of Saniona AB to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Please note, there is a significant difference between Saniona AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Saniona AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Saniona AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.